Home Newsfeeds BTIG Downgrades Globus Medical to Neutral

BTIG Downgrades Globus Medical to Neutral

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.

byBenzinga Newsdesk

February 10, 2023

1 minute read

BTIG analyst Ryan Zimmerman downgrades Globus Medical (NYSE:GMED) from Buy to Neutral.

Reported Late Monday April 3, SNDL And Nova Cannabis Announce An Amendment To The Previously Announced Transformational Strategic Partnership;

By Happy Mohamed

April 4, 12:47 AM

This news release constitutes a "designated news release" for the purposes of the prospectus supplement of Nova Cannabis Inc. dated July 22, 2022, to its short form base shelf prospectus dated June

SNDL

UnitedHealth Q2 Earnings Surpass Street View Led By Growth In Both Segments, Lifts FY22 Earnings Outlook

By Vandana Singh

July 15, 6:33 AM

UnitedHealth Group Inc (NYSE:UNH) has reported Q2 FY22 sales of $80.3 billion, up 13% Y/Y, beating the consensus of $79.68…

UNH

Microsoft Under FTC Investigation For Inflection AI Acquisition Strategy: Report

By Shivani Kumaresan

June 6, 6:25 AM

Microsoft Corp. is reportedly under FTC scrutiny for its $650 million deal with Inflection AI. The FTC is investigating if Microsoft designed the agreement to bypass antitrust review, potentially leading to fines and suspension of the deal. This investigation is part of the FTC's broader effort to monitor AI investments by major tech companies.

GOOGL